| Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America PG Pappas, CA Kauffman, DR Andes, CJ Clancy, KA Marr, ... Clinical infectious diseases 62 (4), e1-e50, 2016 | 4505 | 2016 |
| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 2358 | 2020 |
| Candida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison toC. albicans PL Fidel Jr, JA Vazquez, JD Sobel Clinical microbiology reviews 12 (1), 80-96, 1999 | 1484 | 1999 |
| Multicenter clinical evaluation of the (1→ 3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans L Ostrosky-Zeichner, BD Alexander, DH Kett, J Vazquez, PG Pappas, ... Clinical Infectious Diseases 41 (5), 654-659, 2005 | 947 | 2005 |
| Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis PG Pappas, CMF Rotstein, RF Betts, M Nucci, D Talwar, JJ De Waele, ... Clinical infectious diseases 45 (7), 883-893, 2007 | 785 | 2007 |
| Prospective multicenter surveillance study of funguria in hospitalized patients CA Kauffman, JA Vazquez, JD Sobel, HA Gallis, DS McKinsey, ... Clinical Infectious Diseases 30 (1), 14-18, 2000 | 689 | 2000 |
| A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in … JH Rex, PG Pappas, AW Karchmer, J Sobel, JE Edwards, S Hadley, ... Clinical infectious diseases 36 (10), 1221-1228, 2003 | 560 | 2003 |
| T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial E Mylonakis, CJ Clancy, L Ostrosky-Zeichner, KW Garey, GJ Alangaden, ... Clinical Infectious Diseases 60 (6), 892-899, 2015 | 471 | 2015 |
| Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo JD Sobel, CA Kauffman, D McKinsey, M Zervos, JA Vazquez, ... Clinical infectious diseases 30 (1), 19-24, 2000 | 446 | 2000 |
| Identification of COVID-19 can be quicker through artificial intelligence framework using a mobile phone–based survey when cities and towns are under quarantine ASRS Rao, JA Vazquez Infection Control & Hospital Epidemiology 41 (7), 826-830, 2020 | 440 | 2020 |
| Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis JW Chow, LA Thal, MB Perri, JA Vazquez, SM Donabedian, DB Clewell, ... Antimicrobial agents and chemotherapy 37 (11), 2474-2477, 1993 | 435 | 1993 |
| Effect and safety of meropenem–vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial RG Wunderink, EJ Giamarellos-Bourboulis, G Rahav, AJ Mathers, ... Infectious diseases and therapy 7 (4), 439-455, 2018 | 430 | 2018 |
| Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America PG Pappas, CA Kauffman, DR Andes, CJ Clancy, KA Marr, ... Clinical Infectious Diseases 62 (4), 409-417, 2016 | 400 | 2016 |
| Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens I Raad, R Darouiche, J Vazquez, A Lentnek, R Hachem, H Hanna, ... Clinical infectious diseases 40 (3), 374-380, 2005 | 360 | 2005 |
| Effect of meropenem-vaborbactam vs piperacillin-tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection: the TANGO I … KS Kaye, T Bhowmick, S Metallidis, SC Bleasdale, OS Sagan, V Stus, ... Jama 319 (8), 788-799, 2018 | 336 | 2018 |
| Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis V Moudgal, T Little, D Boikov, JA Vazquez Antimicrobial agents and chemotherapy 49 (2), 767-769, 2005 | 330 | 2005 |
| Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in … JA Vazquez, LD González Patzán, D Stricklin, DD Duttaroy, Z Kreidly, ... Current medical research and opinion 28 (12), 1921-1931, 2012 | 267 | 2012 |
| Anidulafungin: a novel echinocandin JA Vazquez, JD Sobel Clinical infectious diseases 43 (2), 215-222, 2006 | 266 | 2006 |
| International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia L Ostrosky-Zeichner, D Kontoyiannis, J Raffalli, KM Mullane, J Vazquez, ... European Journal of Clinical Microbiology and Infectious Diseases 24, 654-661, 2005 | 228 | 2005 |
| A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS JA Vazquez, DJ Skiest, L Nieto, R Northland, I Sanne, J Gogate, ... Clinical infectious diseases 42 (8), 1179-1186, 2006 | 225 | 2006 |
peter pappasUniversity of Alabama at BirminghamVerified email at uab.edu